Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 8/20 | 0.54 |
| ▸ | LTA4H | P09960 | 4/20 | 0.47 |
| ▸ | CACNA1B | Q00975 | 3/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4797968 | 0.97 | HSD17B3 (0.59) | HSD17B3LTA4HCACNA1BMGLLABHD6 | |
| SCHEMBL6389952 | 0.94 | HSD17B3 (0.58) | HSD17B3LTA4HCACNA1BHRH3KCNH2 | |
| SCHEMBL6388533 | 0.90 | HSD17B3 (0.64) | HSD17B3LTA4HCACNA1BHRH3KCNH2 | |
| SCHEMBL4801272 | 0.82 | HSD17B3 (0.63) | HSD17B3HRH3 | |
| SCHEMBL4796687 | 0.79 | HSD17B3 (0.69) | HSD17B3HRH3 | |
| Trifluoroacetic Acid SCHEMBL4799170 | 0.79 | HSD17B3 (0.66) | HSD17B3 | |
| SCHEMBL4797138 | 0.78 | HSD17B3 (0.48) | HSD17B3CACNA1B | |
| SCHEMBL4799800 | 0.77 | HSD17B3 (0.65) | HSD17B3LTA4H | |
| Trifluoroacetic Acid SCHEMBL4799599 | 0.75 | HSD17B3 (0.73) | HSD17B3 | |
| SCHEMBL4797125 | 0.72 | HSD17B3 (0.66) | HSD17B3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7417040-B2 | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-08-26 | — | — | US | disclosed |